Literature DB >> 20884128

[¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.

Steven F Petit1, Wouter J C van Elmpt, Cary J G Oberije, Erik Vegt, Anne-Marie C Dingemans, Philippe Lambin, André L A J Dekker, Dirk De Ruysscher.   

Abstract

PURPOSE: Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [(18)F]fluorodeoxyglucose ([(18)F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. METHODS AND MATERIALS: We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [(18)F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [(18)F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [(18)F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression.
RESULTS: Increased lung density and pretreatment [(18)F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [(18)F]FDG uptake in the lungs remained significant in multivariable logistic regression (p = 0.016; odds ratio [OR] = 4.3), together with age (p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 (p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy.
CONCLUSIONS: The risk of RILT increased with the 95th percentile of the [(18)F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [(18)F]FDG uptake.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20884128     DOI: 10.1016/j.ijrobp.2010.06.016

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

Review 1.  Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities.

Authors:  Wouter van Elmpt; Catharina M L Zegers; Marco Das; Dirk De Ruysscher
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.

Authors:  Richard Castillo; Ngoc Pham; Edward Castillo; Samantha Aso-Gonzalez; Sobiya Ansari; Brian Hobbs; Diana Palacio; Heath Skinner; Thomas M Guerrero
Journal:  Radiology       Date:  2015-01-13       Impact factor: 11.105

3.  Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.

Authors:  M Thor; Jo Deasy; A Iyer; E Bendau; A Fontanella; A Apte; E Yorke; A Rimner; A Jackson
Journal:  Radiother Oncol       Date:  2019-05-27       Impact factor: 6.280

Review 4.  Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques.

Authors:  Sonja Stieb; Kendall Kiser; Lisanne van Dijk; Nadia Roxanne Livingstone; Hesham Elhalawani; Baher Elgohari; Brigid McDonald; Juan Ventura; Abdallah Sherif Radwan Mohamed; Clifton David Fuller
Journal:  Hematol Oncol Clin North Am       Date:  2019-10-31       Impact factor: 3.722

5.  Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio.

Authors:  Tomoko Ueyama; Takeshi Arimura; Koji Takumi; Fumihiko Nakamura; Ryutaro Higashi; Soichiro Ito; Yoshihiko Fukukura; Tomokazu Umanodan; Masanori Nakajo; Chihaya Koriyama; Takashi Yoshiura
Journal:  Br J Radiol       Date:  2018-04-16       Impact factor: 3.039

6.  Multimodality molecular imaging of the lung.

Authors:  Delphine L Chen; Paul E Kinahan
Journal:  Clin Transl Imaging       Date:  2014-10-16

Review 7.  PET in the management of locally advanced and metastatic NSCLC.

Authors:  Willem Grootjans; Lioe-Fee de Geus-Oei; Esther G C Troost; Eric P Visser; Wim J G Oyen; Johan Bussink
Journal:  Nat Rev Clin Oncol       Date:  2015-04-28       Impact factor: 66.675

8.  Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study.

Authors:  Sarah Abdulla; Ali Salavati; Babak Saboury; Sandip Basu; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-02       Impact factor: 9.236

9.  Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.

Authors:  Howard J Lee; Jing Zeng; Hubert J Vesselle; Shilpen A Patel; Ramesh Rengan; Stephen R Bowen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

Review 10.  Radiation-Induced Lung Injury-Current Perspectives and Management.

Authors:  Mandeep Singh Rahi; Jay Parekh; Prachi Pednekar; Gaurav Parmar; Soniya Abraham; Samar Nasir; Rajamurugan Subramaniyam; Gini Priyadharshini Jeyashanmugaraja; Kulothungan Gunasekaran
Journal:  Clin Pract       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.